The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis
Corresponding Author
Hannah Kuper Sc.D.
Department of Epidemiology and Public Health, University College London, London, UK
Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, England.fax: (44) 020-7813-0242===Search for more papers by this authorWeimin Ye
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorUlrika Broomé
Department of Gastroenterology, Huddinge Hospital, Stockholm, Sweden
Search for more papers by this authorAnders Romelsjö
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorLorelei A. Mucci
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorAnders Ekbom
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorHans-Olov Adami
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorDimitrios Trichopoulos
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorOlof Nyrén
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorCorresponding Author
Hannah Kuper Sc.D.
Department of Epidemiology and Public Health, University College London, London, UK
Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, England.fax: (44) 020-7813-0242===Search for more papers by this authorWeimin Ye
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorUlrika Broomé
Department of Gastroenterology, Huddinge Hospital, Stockholm, Sweden
Search for more papers by this authorAnders Romelsjö
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorLorelei A. Mucci
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorAnders Ekbom
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorHans-Olov Adami
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorDimitrios Trichopoulos
Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Search for more papers by this authorOlof Nyrén
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorAbstract
No prospective study has analyzed simultaneously chronic viral hepatitis and alcoholism as risk factors for liver carcinogenesis, while taking into consideration the role of cirrhosis. Nor has the risk for hepatocellular carcinoma among patients with chronic viral hepatitis been prospectively evaluated in a low-risk Western population. Last, the relationship between hepatocellular carcinoma risk factors and bile duct cancer remains to be clarified. We analyzed prospectively the risk for primary liver and extrahepatic biliary tract cancer among 186,395 patients hospitalized with either chronic viral hepatitis, alcoholism, cirrhosis, or any combination of these conditions through linkages between national Swedish registers. Compared with the general population, the relative risk of hepatocellular carcinoma was 34.4 for chronic viral hepatitis alone, 2.4 for alcoholism alone, and 40.7 for cirrhosis alone. Among patients with combinations of these risk conditions, the relative risk of hepatocellular carcinoma was 27.3 for chronic viral hepatitis and alcoholism, 118.5 for chronic viral hepatitis and cirrhosis, 22.4 for alcoholism and cirrhosis, and 171.4 for all 3 conditions. We found limited evidence for an excess risk of intrahepatic, but not for extrahepatic, biliary duct cancer. Cirrhosis amplifies the risk of hepatocellular carcinoma among patients with chronic viral hepatitis, but it is not a prerequisite for liver carcinogenesis. In contrast, cirrhosis may be a necessary intermediate for the development of hepatocellular carcinoma among alcoholics.
References
- 1 Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33–64.MEDLINE
- 2 El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745–750.MEDLINE
- 3 IARC. Hepatitis viruses. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 59. Lyon: IARC, 1994.
- 4 IARC. Alcohol drinking. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 44. Lyon: IARC, 1988.
- 5 Adami HO, McLaughlin JK, Hsing AW, Wolk A, Ekbom A, Holmberg L, Persson I. Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 1992; 3: 419–425.MEDLINE
- 6 Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985; 14: 64–69.MEDLINE
- 7 Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biomet Bull 1946; 2: 47–53.
- 8 La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998; 7: 315–320.MEDLINE
- 9 Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology 1999; 29: 1425–1428.MEDLINE
- 10
Donato F,
Boffetta P,
Puoti M.
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.
Int J Cancer
1998;
75: 347–354.MEDLINE
10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2 CAS PubMed Web of Science® Google Scholar
- 11 Trichopoulos D, Day NE, Kaklamani E, Tzonou A, Muñoz N, Zavitsanos X, Koumantaki Y, et al. Hepatitis B vius, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma. Int J Cancer 1987; 39: 45–49.MEDLINE
- 12 Chung RT, Liang TJ. Hepatitis C virus and hepatocellular carcinoma. In: J Parsonnet, ed. Microbes and Malignancy, Infections as a Cause of Human Cancers. New York: Oxford University Press, 1999; 267–288.
- 13 Robinson WS. Hepatitis B virus and hepatocellular carcinoma. In: J Parsonnet, ed. Microbes and Malignancy, Infections as a Cause of Human Cancers. New York: Oxford University Press, 1999; 232–267.
- 14 Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 1997; 26: 579–584.MEDLINE
- 15 Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 1997; 26: 485–490.MEDLINE
- 16 Kim YI, Yang DH, Chang KR. Relationship between Clonorchis sinensis infestation and cholangiocarcinoma of the liver in Korea—epidemiological and pathologic reappraisal of 495 consecutive primary carcinomas of the liver in Seoul and Pusan areas. Seoul J Med 1974; 15: 247–255.
- 17
Srivatanakul P,
Parkin DM,
Jiang YZ,
Khlat M,
Kao-Ian UT,
Sontipong S,
Wild C.
The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study.
Cancer
1991;
68: 2411–2417.MEDLINE
10.1002/1097-0142(19911201)68:11<2411::AID-CNCR2820681114>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- 18 Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998; 27: 311–316.MEDLINE
- 19 Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000; 31: 7–11.MEDLINE
- 20
Altaee MY,
Johnson PJ,
Farrant JM,
Williams R.
Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.
Cancer
1991;
68: 2051–2055.MEDLINE
10.1002/1097-0142(19911101)68:9<2051::AID-CNCR2820680934>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 21 Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933–940.MEDLINE
- 22
Okuda K,
Kubo Y,
Okazaki N,
Arishima T,
Hashimoto M.
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
Cancer
1977;
39: 232–246.MEDLINE
10.1002/1097-0142(197701)39:1<232::AID-CNCR2820390137>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- 23 Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, Adami HO. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 1993; 342: 1262–1265.MEDLINE
- 24 Khan ZR, Neugut AI, Ahsan H, Chabot JA. Risk factors for biliary tract cancers. Am J Gastroenterol 1999; 94: 149–152.MEDLINE
- 25 Kato I, Nomura AM, Stemmermann GN, Chyou PH. Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites. Cancer Causes Control 1992; 3: 145–151.MEDLINE
- 26 Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N, Myerson RJ. Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 1994; 55: 239–245.MEDLINE
- 27 Chow WH, McLaughlin JK, Menck HR, Mack TM. Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 1994; 5: 267–272.MEDLINE
- 28 Moerman CJ, Bueno de Mesquita HB, Runia S. Smoking, alcohol consumption and the risk of cancer of the biliary tract; a population-based case-control study in The Netherlands. Eur J Cancer Prev 1994; 3: 427–436.MEDLINE
- 29 Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, Jain M, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997; 89: 1132–1138.MEDLINE